Latest Articles
Former paramedic vows to 'fight as hard as I can' after cervical cancer returns as stage four disease - SussexWorld
Former paramedic vows to 'fight as hard as I can' after cervical cancer returns as stage four disease SussexWorld
Published: June 4, 2026, 2:40 p.m.
KPTI: Phase III data in myelofibrosis and endometrial cancer signal major advances and rapid adoption - TradingView
KPTI: Phase III data in myelofibrosis and endometrial cancer signal major advances and rapid adoption TradingView
Published: June 4, 2026, 1:28 p.m.
AstraZeneca removing breast cancer drug from Australia - Australian Broadcasting Corporation
AstraZeneca removing breast cancer drug from Australia Australian Broadcasting Corporation
Published: June 4, 2026, 8 a.m.
A Crucial Cancer Drug is Withdrawn from Australia, Leaving Thousands in Limbo - streamlinefeed.co.ke
A Crucial Cancer Drug is Withdrawn from Australia, Leaving Thousands in Limbo streamlinefeed.co.ke
Published: June 4, 2026, 7:23 a.m.
A Key Endometriosis & Breast Cancer Drug Is Being Pulled From Australia: 'Deeply Concerned' - pedestrian.tv
A Key Endometriosis & Breast Cancer Drug Is Being Pulled From Australia: 'Deeply Concerned' pedestrian.tv
Published: June 4, 2026, 5:34 a.m.
I’m Cancer-Free After 14 Years, Says Robin Quivers - Health and Me
I’m Cancer-Free After 14 Years, Says Robin Quivers Health and Me
Published: June 4, 2026, 4:43 a.m.
AstraZeneca to Withdraw Life-Saving Breast Cancer Drug from Australian Market This Year - SSBCrack
AstraZeneca to Withdraw Life-Saving Breast Cancer Drug from Australian Market This Year SSBCrack
Published: June 4, 2026, 1:03 a.m.
Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis.
Endometriosis is a common gynecologic disorder often associated with chronic pelvic pain, infertility, and reduced quality of life. Conventional imaging modalities, such as transvaginal ultrasound and MRI, may underestimate the …
Published: June 4, 2026, midnight
Deciphering the Pleiotropic Role of ARID1a and RIF1 in Endometrioid Ovarian Cancer.
Given the challenges in early detection and diagnosis, understanding the molecular underpinnings of endometrioid ovarian cancer (EOC) is crucial for improving patient outcomes. This multi-level study provides a new perspective …
Published: June 4, 2026, midnight
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 - Karyopharm
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 Karyopharm
Published: June 3, 2026, 10:53 p.m.
Link copied to clipboard!